A new study published in JAMA Network Open by an international cohort of researchers provides the latest data on the effectiveness of treating...

OSAKA, Japan and CAMBRIDGE, Massachusetts, June 22, 2024 – Takeda (TSE:4502/NYSE:TAK) today presented positive results from its Phase 2b,...

A new study adds to a large body of evidence on the effectiveness of movement for treating and preventing pain.

THURSDAY, June 20, 2024 -- About one-third of community outpatient mental health treatment facilities (MHTFs) offer medications for opioid use...

These non-invasive, non-pharmacological techniques encompass meditation-based modalities that offer profound benefits increasingly validated by modern...

Beam Therapeutics (BEAM) doses the first patient in a phase I/II study, evaluating in vivo base editor BEAM-302 for treating alpha-1 antitrypsin...

WHO estimates that there are 39 million HIV patients living in the world with a death rate of around 630,000 per year. A figure that seems high but 20...

People with type 2 diabetes who are treated with GLP-1 agonists have a decreased risk of developing dementia, according to a new study from...

THURSDAY, June 27, 2024 -- Just 25% of people battling opioid use disorder are getting medications aimed at helping them quit and potentially avoid an...

Rielly McLaren says the grief caused by toxic drug deaths feels staggering and palpable in his community. McLaren, who pastors Windsor Mennonite...